Antiviral Therapeutics: Global Technologies, Markets & Companies, 2018-2019 & 2028

Ads

You May Also Like

Evogene Reports Fourth Quarter and Full Year 2017 Financial Results

REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading ...

Cellectar Biosciences Reports Second Quarter 2017 Financial and Corporate Performance

MADISON, Wis., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...